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Purpose: Acute kidney injury (AKI) is a frequent complication after cardiac surgery and is associated with
increased mortality. The aim was to design a nondialytic AKI score in patients with previously normal renal
function undergoing cardiac surgery.
Methods: Data were collected on 909 patients who underwent cardiac surgery with cardiopulmonary bypass be-
tween 2012 and 2014. A total of 810 patients fulﬁlled the inclusion criteria. Patients were classiﬁed as having AKI
based on the RIFLE criteria. Postoperative AKI occurred in 137 patients (16.9%). Several parameters were recorded
preoperatively, intraoperatively, and at intensive care unit admission, looking for a univariate andmultivariate asso-
ciationwithAKI risk. A seconddata set of 741patients, from2differenthospitals,was recordedas a validation cohort.
Results: Four independent risk factors were included in the CRATE score: creatinine (odds ratio [OR], 9.66; 95% con-
ﬁdence interval [CI], 4.77-19.56; P b .001), EuroSCORE (OR, 1.40; CI, 1.29-1.52; P b .001), lactate (OR, 1.03; CI, 1.01-
1.04; P b .001), and cardiopulmonary bypass time (OR, 1.01; CI, 1.01-1.02; P b .001). The accuracy of the model was
good, with an area under the curve of 0.89 (CI, 0.85-0.92). The CRATE score retained good discrimination in valida-
tion cohort, with an area under the curve of 0.81 (95% CI, 0.78-0.85).
Conclusions: CRATE score is an accurate and easy to calculate risk score that uses affordable andwidely available var-
iables in the routine care surgical patients.
© 2015 Published by Elsevier Inc.1. Introduction
Acute kidney injury (AKI) is a frequent and severe complication after
cardiac surgery, being this kind of surgery the second most common
cause of AKI in the intensive care unit (ICU) [1]. In this context and
depending on the deﬁnition used, AKI could affect up to 39% of patients
undergoing cardiac surgery procedures, with 1% to 5% needing renal
replacement therapy (RRT) [2]. Patients developing AKI have increased
morbidity and worse surviving rates than those with normal renal
function. In addition, it increases ICU and inhospital stay, risk of
infection, and hospitalization cost [3]. Therefore, AKI is an important
complication closely related to cardiac surgery using cardiopulmonary
bypass (CPB). This particular relation gave rise to the appearance of
the term cardiac surgery–associated acute kidney injury (CSA-AKI) [4].r Surgery, Hospital Universitario
34 915202201.
Bustamante-Munguira).Risk stratiﬁcation has become essential in cardiac surgical practice,
speciﬁcally focused inmortality (ie, EuroSCORE and ACEF score) [5]. Be-
cause of the implications of CSA-AKI in outcome, this clinical entity has
been targeted in risk stratiﬁcation models. Previously, some authors
have developed several algorithms trying to predict renal failure not re-
quiring dialysis [6]. TheMulticenter Study of Perioperative Ischemia Re-
search Group (MCSPI) model proposed by Aronson et al [7] included
patients who underwent coronary artery bypass grafting (CABG) sur-
gery, evaluating preoperative and intraoperative variables. Brown et al
[8] produced an algorithm, the Northern New England Cardiovascular
Disease Study Group (NNECDSG) score, with preoperative characteris-
tics that included patients scheduled for CABG. None of these models
take into account the early postoperative period, which is considered
by some authors as the best time to apply a cardiac surgery–speciﬁc
score because of the inﬂuence of intraoperative variables in the clinical
course of these patients [9]. Therefore, it would be necessary to use a
clinical tool estimating the risk by using preoperative, intraoperative,
and postoperative variables. Palomba et al [9] followed up 603 patients
131P. Jorge-Monjas et al. / Journal of Critical Care 31 (2016) 130–138after CABG, valvular surgery, or both, developing the acute kidney injury
following cardiac surgery (AKICS) score. They added postoperative
period data (central venous pressure and low cardiac output) to
preoperative and intraoperative items in their model [9]. However,
these previous 3 scores because of the AKI deﬁnition used may not
predict less severe cases of AKI, which was previously shown as an
important factor in morbidity and mortality [2,10,11].
Our hypothesis is that using AKI risk factors from the preoperative
and intraoperative period and adding organ function assessment vari-
ables obtained in the early postoperative period, it would be possible
to create an accurate score for predicting AKI risk. The aim of this
study was to design a nondialytic AKI risk score, including less severe
cases, in patients with previously normal renal function undergoing
cardiac surgery with CPB.
2. Materials and methods
2.1. Study design
A prospective open cohort study was designed to assess risk factors
for AKI after cardiac surgery with CPB, carried out between January
2012 and January 2014 in the Clinic University Hospital, Valladolid
(Spain), a level III health care medical center with 800 beds. Patients
were classiﬁed as having CSA-AKI based on the RIFLE criteria [3] using
the peak postoperative plasma creatinine in the ICU. For baseline
creatinine, we used that of hospital admission. Patients who met the
RIFLE criteria for CSA-AKI (Risk, Injury and Failure) were classiﬁed as
“AKI,” whereas those who did not were classiﬁed as “NON-AKI.” Those
patients who required RRT (RIFLE class L or E) were classiﬁed into F
category to avoid losing cases. Staging these patients in F class can
improve the predictive value of this system [12].
The Valladolid Clinic UniversityHospital Ethics Committee approved
the study and waived the need for an informed consent of the patients,
who, however, gave their written consent to the storage in the hospital
database for scientiﬁc treatment of their data in an anonymous form at
the time of the hospital admission, according to the Spanish law regulating
personal privacy matters.
The validation cohort consisted of consecutive cases at the Valladolid
Clinic University Hospital and at La Princesa University Hospital be-
tween March 2014 and March 2015. This validation process evaluated
the generalizability based on a differing geographic data collection and
applied to a different period [13].
2.2. Study population
During the 3-year period of the study, adult patients (18 years or
older) with normal renal function, scheduled for CABG and/or valve
surgery with CPB, were included. Transplant patients, patients with
any degree of renal insufﬁciency (acute or chronic), those who died in
the ﬁrst 24 hours after the surgery, and patients undergoing off-pump
cardiac procedures were excluded. A total of 1551 patients from 2
different institutions were included. A total of 810 patients were
enrolled consecutively as a score development cohort, whereas the
validation cohort consisted of 741 patients.
2.3. Intraoperative care and anesthesia
Induction of anesthesia was initiated with intravenous midazolam
and etomidate. Rocuronium was used to achieve neuromuscular block-
ade. The lungs were ventilated with an oxygen/air mixture to maintain
normocapnia. Sevoﬂurane, midazolam, and fentanyl were used in
combination for maintenance of anesthesia. A radial, brachial, or
femoral artery catheter was inserted for measurement of arterial
blood pressure and blood sampling; and a trilumen internal jugular
catheter, for measurement of central venous pressure, blood sampling,
and ﬂuid/medication administration. Temperature was obtained withan esophageal probe. Urine output was measured with a Foley catheter.
Five-lead electrocardiogram was monitored continuously. Cardiopul-
monary bypass with systemic heparinization (350 U/kg) was started.
Additional heparin boluses were administered to maintain an activated
clotting time greater than 400 seconds. Pumpﬂows from45 to 55mL/kg
perminute,moderate systemic hypothermia (28°C-30°C), and intermit-
tent cold blood cardioplegia were used for most patients. The mean
arterial pressure was maintained between 60 and 80 mm Hg. Heparin
was reversed with protamine at a 1.5:1 ratio after completion of CPB
and removal of cannulae.
2.4. Postoperative care
When surgery was ﬁnished, patients were transferred to the
ICU, where they were treated according to a standard regimen.
Hemodynamic values were assessed at heart rate at 70 to 80 beats per
minute and mean arterial pressure at 65 to 80 mm Hg, using
vasopressor and/or inotropic support depending on individual status
of the patient. Basic intravenous ﬂuid administration consisted of 0.9%
NaCl, and gelatin was infused if needed. Fluid balance, rectal tempera-
ture, peripheral temperature (axillary), and drainage output were
recorded every hour. Mechanical ventilation was performed with 50%
oxygen using volume-controlled ventilation and tidal volume of 6 to 8
mL/kg with 5 cm H2O of positive end-expiratory pressure. Sedation
was provided with propofol and analgesia with morphine boluses as
required. Samples of arterial blood gases were analyzed by standard
techniques using an automated analyzer at anesthesia induction and
at 4-hour intervals for 24 hours after ﬁnishing CPB. In addition, labora-
tory tests including biochemistry, coagulation, and blood cell count
were performed when patient was admitted to the ICU and 6 hours
later. Chest radiography at the admission in ICU was used to assess the
correct position of the central venous line. Extubation occurred in
the ICU using the following criteria: Tobin index (respiratory rate
[spontaneous]/tidal volume [liters]) less than 105; PaO2 greater than
60 mm Hg; fraction of inspired oxygen (FIO2) less than 0.4; continuous
positive airway pressure less than 5 mbar, PaCO2 less than 50 mm Hg,
and arterial pH greater than 7.35.
2.5. Study variables
2.5.1. Outcome variables
The primary outcome variable was any degree of AKI, measured by
RIFLE criteria (Risk, Injury and Failure).
2.5.2. Independent variables
Preoperative, intraoperative, and postoperative potential risk factors
for AKI and parameters at admission in the ICU (see below) were
deﬁned as independent variables. The preoperative risk for operative
mortality was evaluated by additive and logistic EuroSCORE 1.
2.5.3. Data collection
The following data were recorded prospectively for all patients:
The following preoperative characteristics were documented: age,
sex, weight, height, body surface area, coexisting disease or condition
(systemic and pulmonary arterial hypertension, atrialﬁbrillation, diabe-
tes mellitus, hepatic disease, chronic obstructive pulmonary disease,
and immunosuppression), previous cardiac surgery, preoperative
creatinine, left ventricular ejection fraction, type of surgery (isolated
valve surgery, CABG, combined valve+CABG, and surgery of the ascend-
ing aorta, emergent surgery), and EuroSCORE (standard and logistic).
Intraoperative characteristics are as follows: CPB time and aortic
cross-clamp time, lactate, and C-reactive protein.
Postoperative characteristics are as follows: duration of mechanical
ventilation, time to extubation, reintubation, tracheotomy, use
of vasopressor drugs, red blood cell transfusion, acute renal failure,
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inhospital stay, and mortality.2.5.4. Parameters at admission to the ICU
The following data were collected immediately at the admission
in the ICU: pH, bicarbonate (HCO3), partial pressure of carbonic
anhydride (PaCO2), PaO2/FIO2 ratio, CO2 arteriovenous difference, central
venous oxygen saturation (ScvO2), leukocyte, C-reactive protein,
procalcitonin, lactate, glucose, creatinine, hematocrit, sodium (Na),
potassium (K), troponin T, creatine kinase-MB, international
normalized ratio (INR), activated partial thromboplastin time ratio,
and platelet count.
Core temperature, heart rate, mean arterial pressure, urinary output,
amount ofﬂuids infused in theﬁrst 24hours, andﬂuid balancewere col-
lected. In all cases, hemodynamic parameters (heart rate and mean ar-
terial pressure) were registered 30 minutes after admission to the ICU
and once the patient had reached hemodynamic stability.Table 1
Patient population proﬁle (AKI and NON-AKI)
Variable NON-AKI, 673 (83.1%) AKI, 137 (16.9%) P
Perioperative factors
Age (y) 66.2 ± 10.9 70.0 ± 10.3 b .001
Weight (kg) 72.9 ± 15.7 70.7 ± 10.3 .04
Height (cm) 163.4 ± 9.3 161.8 ± 7.5 .03
LVEF (%) 57.3 ± 10.9 51.1 ± 13.9 b .001
Logistic EuroSCORE 1 (%) 4.6 ± 4.9 12.9 ± 13.2 b .001
Additive EuroSCORE 1 (points) 4.21 ± 2.57 7.61 ± 3.33 b .001
Hypertension 363 (53.9) 83 (60.6) .15
Atrial ﬁbrillation 127 (18.9) 48 (27.4) b .001
Previous cardiac surgery 63 (9.4) 13 (17.1) .96
Type 2 diabetes mellitus 97 (14.4) 33 (24.1) .005
Smoking 93 (13.8) 14 (10.2) .26
Alcohol 43 (6.4) 7 (5.1) .57
Emergent surgery 34 (5.1) 37 (27.0) b .001
Statins 362 (53.8) 61 (44.5) .048
β-Blockers 384 (57.1) 43 (31.4) b .001
Poor mobility 22 (3.3) 13 (9.5) .001
Pulmonary hypertension N60 37 (5.5) 19 (13.9) b .001
Endocarditis 15 (2.2) 7 (5.1) .06
Recent myocardial infarction 66 (9.8) 33 (24.1) b .001
Arteriopathy 55 (8.2) 19 (13.9) .03
Previous cardiac surgery 29 (4.3) 12 (8.8) .03
Critically ill 10 (1.5) 25 (18.2) b .001
Valve replacement 413 (61.4) 84 (61.3) .991
CABG 334 (49.6) 64 (46.7) .53
Valve + CABG 91 (13.5) 27 (19.7) .06
Intraoperative factors
Total CPB time (min) 107.8 ± 37.2 143.4 ± 56.5 b .001
Aortic cross-clamp time (min) 78.6 ± 31.4 105.1 ± 46.5 b .001
Lactate during surgery (mg/dL) 19.4 ± 8.3 21.3 ± 8.6 .24
CRP during surgery (mg/L) 9.3 ± 27.8 17.5 ± 40.3 .13
Postoperative factors
Sepsis 11 (1.6) 14 (10.2) b .001
Septic shock 8 (1.2) 20 (14.6) b .001
Reintubation 10 (1.5) 23 (16.8) b .001
Multiple transfusion 219 (32.5) 34 (24.8) .075
RRT 0 (0.0) 19 (13.9) b .001
Tracheostomy 16 (2.4) 22 (16.9) b .001
Reintervention 15 (2.2) 12 (8.8) b .001
IABP 15 (2.2) 29 (21.2) b .001
Cardiac arrest 15 (2.2) 41 (29.9) b .001
ICU readmission 9 (1.3) 15 (10.9) b .001
Pneumonia 19 (2.8) 22 (16.1) b .001
Values are expressed as numbers (n), percentages (%), andmeans±SD. LVEF indicates left
ventricular ejection fraction; CRP, C-reactive protein; IABP, intraaortic balloon pump.2.6. Statistical analysis
Statistical analyseswere performed using the IBMStatistical Package
for Social Sciences (IBM SPSS) version 20. Differences between the
2 groups were examined using the Student t test for continuous vari-
ables and Pearson χ2 test for categorical data. P b .05 was considered
signiﬁcant for all statistical tests.
To assess the associations between the preoperative, intraoperative,
and postoperative parameters and AKI after cardiac operations, all
variables determined on preoperative and intraoperative period and
on admission to the ICU and which were signiﬁcant in the univariate
analysis were subsequently tested for accuracy with a receiver operating
characteristic (ROC) curve analysis, with the area under the curve (AUC)
as a measurement of accuracy, according to the methodology used and
validated in other studies [14].
The variables with areas under the ROC curve less than 0.5 were
transformed into their inverses, to observe the same classiﬁcation
criteria with all the variables [15]. The variables with the best AUC
values (AUC N0.7) were used in a subsequent multivariable logistic
analysis. To adjust the coefﬁcients with greater precision (to avoid
losing cases with the rest of the variables that were not signiﬁcant),
the logistic regression was repeated with the variables that had been
signiﬁcant in the previous analysis. This logistic regression model was
tested for calibration with a Hosmer-Lemeshow χ2, and the possible
multicollinearity of themodelwas checkedwith an analysis of tolerance
and inﬂation statistics.
The abovemodel was subsequently translated into an AKI risk score,
developed based on the respective weights of the signiﬁcant variables
(based on their regression coefﬁcients). Using the B coefﬁcients of the
logistic regression, the logit function (Z) was constructed, and the Z
values and each one of the products BiXi were saved as new variables
in the database (Z = B0 + B1X1 + B2X2 +…+ BnXn).
Receiver operating characteristic curves were generated for each of
these new variables and used to identify the cutoff points that deﬁned
the ranges of scores for AKI for each predictor. The cutoff points of the
ROC curves for scores (BiXi) were correlated with the corresponding
values of the original variables. The corresponding BiXi average value
was allocated as a point score to each resultant range of values of the
original variable Xi (predictor) within that particular grouping. The
sum of weighted risk scores was then calculated for each patient. Initial
risk categories for AKI were calculated from the cutoff points deﬁned by
the ROC curve obtained with the overall point score.
Differences between predicted and observed AKI rates were
explored for different risk classes, determined by their cutoff points on
the ROC curve, by comparing predicted/observed event rates with 95%
conﬁdence intervals (CIs).3. Results
3.1. Patient characteristics
During the duration of the study, a total of 909 adult patients were
operated on at the cardiac surgery center concerned. Twelve patients
died in the operating theater. Seventeen patients died during the ﬁrst
24 hours of admission in the ICU. Seventy patients were scheduled for
off-pump cardiac surgery. A total of 810 patients were enrolled in the
study, developing AKI 137 (16.9%). In addition, in the validation cohort,
117 patients (15.7%) developed AKI.
3.2. Differences between AKI and NON-AKI patients
Patients who did not have AKI were younger and had a signiﬁcant
higher operative risk as demonstrated by a higher EuroSCORE 1 values
(Table 1). The AKI group more frequently showed a medical history of
previous atrial ﬁbrillation, diabetes, pulmonary hypertension, poor
mobility, recent myocardial infarction, endocarditis, and arteriopathy.
Furthermore, they underwent emergency surgery or redo interventions
more often. The NON-AKI patients were treated more frequently with
statins and β-blockers. Acute kidney injury patients also showed a
lower left ventricular ejection fraction and had longer CPB and aortic
Table 2
Parameters at admission to the ICU in AKI and NON-AKI patients
n = 810 NON-AKI, 673 (83.1%) AKI, 137 (16.9%) P
pH 7.38 ± 0.06 7.34 ± 0.08 b .001
Bicarbonate (mEq/L) 24.6 ± 3.2 22.7 ± 3.4 b .001
Lactate (mg/dL) 28.1 ± 13.1 48.9 ± 33.3 b .001
Procalcitonin (ng/mL) 0.6 ± 3.8 2.1 ± 7.1 .01
Core temperature (°C) 36.6 ± 0.8 36.9 ± 1.1 b .001
Creatinine (mg/dL) 0.96 ± 0.27 1.35 ± 0.47 b .001
Heart rate (beats per minute) 92.2 ± 17.4 100.8 ± 19.4 b .001
Glucose (mg/dL) 181.6 ± 53.9 189.3 ± 71.9 .23
Leukocyte count (cells/mm3) 10315 ± 6526 12734 ± 5889 b .001
Hematocrit (%) 29.1 ± 4.4 28.2 ± 4.2 .02
Na (mmol/L) 140.2 ± 8.2 141.03 ± 4.2 .22
K (mmol/L) 3.9 ± 0.6 4.1 ± 0.7 b .001
C-reactive protein (mg/L) 12.7 ± 34.02 26.5 ± 48.9 .002
Troponin T (μg/L) 0.76 ± 1.50 1.89 ± 2.73 b .001
CK-MB (ng/mL) 355.5 ± 285.6 219.9 ± 274.1 b .001
MAP (mm Hg) 73.1 ± 12.9 60.9 ± 13.8 b .001
INR (range) 1.53 ± 0.24 1.80 ± 0.50 b .001
aPTT (range) 1.21 ± 0.24 1.46 ± 0.49 b .001
Platelet count (cells/mm3) 118426 ± 44235 115810 ± 56590 .55
ScvO2 (%) 74.3 ± 8.10 66.02 ± 9.78 b .001
PaO2/FIO2 (range) 248 ± 72.7 231 ± 64.9 .013
aCO2 (mm Hg) 40.9 ± 6.13 41.3 ± 6.47 .51
vCO2 (mm Hg) 46.9 ± 6.4 48.9 ± 6.81 .001
Delta CO2 (mm Hg) 5.9 ± 2.9 7.6 ± 3.4 b .001
Inhospital stay (d) 20.3 ± 15.4 35.5 ± 31.1 b .001
ICU stay (d) 3.6 ± 8.6 13.3 ± 18.0 b .001
Values are expressed asmeans± SD. CK-MB indicates creatine kinase-MB;MAP,mean ar-
terial pressure; aPTTr, activatedpartial thromboplastin time ratio; aCO2, arterial carbon di-
oxide partial pressure; vCO2, venous carbon dioxide partial pressure; Delta CO2, venous-
arterial carbon dioxide difference; TnT, troponin T.
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such as sepsis, reintervention, tracheostomy, or pneumonia were statis-
tically signiﬁcant higher in the AKI group, with longer inhospital and
ICU length of stay. Finally, AKI patients had a signiﬁcant highermortality
as demonstrated by Kaplan-Meier analysis (Fig. 1).
3.3. Predictors of CSA-AKI
Patients with AKI and without AKI differed in all parameters mea-
sured on their admission to the ICU except in glucose, sodium, platelet
count, and arterial carbon dioxide partial pressure (Table 2). An ROC
analysis was performed for each one of these variables identiﬁed in
the univariate analyses, with estimation of the AUC and 95% CI. The
variables with the best AUC were standard EuroSCORE 1, CPB time,
and postoperative lactate (ICU lactate), bicarbonate, procalcitonin,
creatinine (ICU creatinine), troponin T, mean arterial pressure, ScvO2,
and INR. These 10 variables were subsequently entered into a multivar-
iate logistic model (forward stepwise). In this analysis, 4 variables
(ICU creatinine, ICU lactate, standard EuroSCORE, and CPB time) were
conﬁrmed to be independent predictors of AKI. We performed the
multivariate logistic model again including only these 4 variables.
Acute kidney injury risk (Table 3) was directly correlated with ICU
creatinine (odds ratio [OR], 9.66; 95% CI, 4.77-19.56), EuroSCORE 1
(OR, 1.40; CI, 1.29-1.52), ICU lactate (OR, 1.03; CI, 1.01-1.04), and
CPB time (OR, 1.01; CI, 1.01-1.02). This multivariate model was well
calibrated (Table 3; see Hosmer-Lemeshow value).
3.4. Development of an AKI score: The CRATE score
The above model, with these 4 variables, was subsequently translat-
ed into an AKI risk score: the CRATE score (Table 4). The AKI risk score
was developed based on the respective weights of the signiﬁcant vari-
ables (based on their regression coefﬁcients; Table 3), and cutoff points
were established by analyzing the ROC curve coordinates for mortality
risk according to the products BiXi. The cutoff points of the ROC curves
deﬁne the different points scale for each of the BiXi variables (Fig. 2).
We assigned the median value of the corresponding BiXi value in that
same range (p.e. “Lactate score”= 13 in the above “Lactate” range for
BiXi = 0.031 * [“Lactate”]) to the interval deﬁned by the minimum-Fig. 1. Kaplan-Meier analysis of 30- and 90-dmaximum of each original variable in that group (p.e. “Lactate” 36.9 to
51.0 mg/dL).
The new scale was applied to the database, and a total point score
was calculated: CRATE (total score) = CReatinine score + lactic Acid
score+ CPB Time score+ EuroSCORE 1 score. The CRATE score created
with these 4 variables was tested for signiﬁcance, accuracy, and calibra-
tion using a logistic regression model with Hosmer-Lemeshow χ2 and
ROC analysis (Table 5). The CRATE score was signiﬁcantly (P b .001)ay inhospital survival based on CSA-AKI.
Table 3
Logistic regression model: risk factors for CSA-AKI
B SE P OR 95% CI
Constant −8.422 0.626 b .001
Additive EuroSCORE (points) 0.336 0.042 b .001 1.400 1.288-1.521
CPB time (min) 0.010 0.003 b .001 1.010 1.005-1.016
Lactate (mmol/L) 0.031 0.007 b .001 1.031 1.018-1.045
Creatinine (mg/dL) 2.268 0.360 b .001 9.658 4.769-19.558
Hosmer-Lemeshow χ2 = 10.46; P= .23. Multicollinearity diagnostics: EuroSCORE, 0.91
tolerance; CPB time, 0.81 tolerance; lactate, 0.78 tolerance; and creatinine, 0.87 tolerance.
B indicates regression coefﬁcient.
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Lemeshow test χ2 = 11.87; P = .16; Table 5). The accuracy was
moderately good, with an AUC of 0.89 (95% CI, 0.85-0.92) (Fig. 3).
3.4.1. Cardiac surgery–associated acute kidney injury risk categories
The probability of AKI was calculated for each of the groupings
determined by the cutoff points of the ROC curve for the total score
(Fig. 2). On this basis, patients were classiﬁed into 6 risk categories,
which were later regrouped into 5: very low (b50 points), low (50-70
points), moderate (70-80 points), high (80-90), and very high (N90
points). The observed AKI was 1.69%, 8.84%, 32.33%, 58.66%, and
84.95%, respectively. The percent probability (95% CI) for these catego-
ries was 1.69 (1.61-1.77), 8.84 (8.3-9.37), 32.33 (30.57-34.09), 58.66
(56.84-60.48), and 84.95 (82.82-87.07), respectively (Table 4).
3.4.2. Score validation
The CRATE score was prospectively validated in a new data set of
741 patients recruited by La Princesa University Hospital, Madrid, and
the Clinic University Hospital in Valladolid. Incidence of AKI was 15.7%
(n = 117). The CRATE score retained good discrimination in validation
cohort. The area under the ROC curve in the validation cohort was 0.81
(95% CI, 0.78-0.85) (Fig. 4).
4. Discussion
The results of this study conﬁrmed the validity of the proposed
hypothesis. An AKI risk score evaluating preoperative, intraoperative,
and postoperative variables, including organ function parameters
assessed upon admission to the ICU, would allow to predict early and
in an accurate manner the risk of developing CSA-AKI when CPB is
used in patient with previously normal renal function. The CRATETable 4
The CRATE score (CReatinine, lactic Acid, cardiopulmonary bypass Time, EuroSCORE) and AKI ri
the ROC curve
Creatinine (mg/dL) Creatinine points
≤0.96 18
0.97-1.26 25
1.27-1.49 30
≥1.50 39
CPB time (min) CPB time points
≤81 7
82-104 9
105-138 12
139-181 15
≥182 20
Risk score Observed n Predicted n %
b50 5 5
50-70 32 32
70-80 27 27 3
80-90 23 23 5
N90 50 50 8score is easy to perform bedside and in the ﬁrst hours of admission in
the critical care unit. Furthermore, this model was developed using
affordable and widely available variables in the routine care of cardiac
surgical patients.
The incidence of AKI in the score development population and in val-
idation cohort was 16.9% and 15.7%, respectively, which is congruent
with previous reports where the incidence of AKI ranged from 5% to
40% [4,9,16]. Three predictive models for CSA-AKI risk not requiring
RRT have been developed so far: NNECDSG [8], MCSPI [7], and AKICS
[9]. Unlike our study, NNECDSG and MCSPI only enrolled patients who
underwent CABG surgery, so their results could not be applied
in other types of cardiac surgery (valve or combined procedures).
Furthermore, none of these models used postoperative variables. The
appearance of renal injury during this period depends on factors such
as previous patient characteristics and several events that take place
during surgery (inadequate myocardial protection, complications that
prolong surgical duration, coagulation abnormalities, hemodynamic
instability, anesthetic-relatedproblems, etc). Thus, it is plausible that in-
traoperative issues can signiﬁcantly modify the preoperative stratiﬁca-
tion risk and increase postoperative risk to higher values than those
calculated before surgery. As we have demonstrated in this study,
organ function assessment variables obtained in the early postoperative
period can estimate the physiologic aggression during CPB. Further-
more, we added preoperative and intraoperative variables to character-
ize and consider the whole process in the stratiﬁcation risk procedure.
One of the biggest difﬁculties in comparing different CSA-AKI scores
is the diverse deﬁnitions used in the categorization of renal injury for
each model; in fact, more than 30 different deﬁnitions have been used
in the previous literature. As such, the 3 aforementioned score systems
use 3 different deﬁnitions to diagnose AKI, and this is the main reason
that could have affected the lack of generalization of this models [17].
RIFLE [3] criteria were proposed as consensus deﬁnition of AKI to stan-
dardize it andmake the comparisons between different studies easy and
reliable. Furthermore, RIFLE criteria have been previously validated in
diagnosing renal injury after cardiac surgery. Balancing limitations and
strengths of both consensus deﬁnitions of AKI, the application of the
RIFLE criteria in patients undergoing cardiac surgery may be preferable
[12]. CRATE is the ﬁrst postoperative stratiﬁcation AKI risk model in
cardiac surgery that uses RIFLE in its deﬁnition, and therefore, it could
be easier to compare with future scores. The variables used in CRATE
(ICU-Creatinine, ICU-lactic Acid, cardiopulmonary bypass Time, and
EuroSCORE 1) have been previously identiﬁed in different studies as
predictors of AKI in cardiac surgery context.sk categorieswith corresponding cumulative risk score for CSA-AKI groups calculated from
Lactate (mg/dL) Lactate points
≤17.90 5
18.00-23.90 6
24.00-36.80 9
36.90-51.00 13
≥51.10 21
EuroSCORE (points) EuroSCORE points
≤2 7
3.0-4.0 10
5.0-7.0 20
8.0-10.0 30
≥11 40
Probability (95% CI) AKI (%) AKI risk categories
1.69 (1.61-1.77) 3.6 Very low
8.84 (8.30-9.37) 27 Low
2.33 (30.57-34.09) 46.7 Moderate
8.66 (56.84-60.48) 63.5 High
4.95 (82.82-87.07) 100 Very high
Fig. 2. Receiver operating characteristic curves for individual scores (BiXi) used in CSA-AKI prediction in dotted line (established cutoff points in solid line).
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has been associated with organ dysfunction and poor outcome in vari-
ous clinical settings, including cardiac surgery [18,19]. Up to 20% of pa-
tients develop HL during or shortly after CPB, and it frequently persists
during the ﬁrst hours of admission in ICU [18]. The main mechanism
of immediate HL after cardiac surgery is an increased rate in lactate pro-
duction and, to a lesser extent, a diminished clearance ability of the liver.
The latter is due to the effect of anesthetics in cellular metabolism and
low core temperature during CPB. The use of catecholamines has also
been related to HL due to changes induced in oxidative glucose metab-
olism [19]. Patients with HL during CPB are suffering from a sort of
masked circulatory shock, whichwill exert its deleterious effects on dif-
ferent organs (mainly on renal function) during the early phases of theTable 5
Development series: predictive function of CRATE score for CSA-AKI risk (logistic
regression)
B SE P OR 95% CI
CRATE 0.114 0.009 b .0001 1.12 1.10-1.14
Constant −9.240 0.653 b .0001 0.00
Hosmer-Lemeshow test χ2 = 11.87; P= .16.postoperative course [18]. In addition, increased levels of blood lactate
have been associated with increased risk of morbidity and mortality
and higher incidence of complications including AKI [19].
Creatinine can bemeasured easily and quickly in blood tests, and it is
a speciﬁc marker of the kidney function. Furthermore, changes in base-
line serum creatinine can reﬂect changes in glomerular ﬁltration rate
[7]. Several studies have shown that increases in serum creatinine
after cardiac surgery are related to the development of CSA-AKI in
both adult and pediatric population [2,10]. In a recent article, Ho et al
[11] have demonstrated that small changes in creatinine, measured at
ICU admission, can improve prediction of AKI. Accordingly, Shaw et al
[20] emphasized that rising serum creatinine levels may be a relevant
parameter in the progression to AKI. Thus, even small postoperative in-
creases in serumcreatininemay assist in the early prediction of AKI [10].
Previous authors have published that duration of CPB is an indepen-
dent risk factor for CSA-AKI, establishing a time limit interval between
115 and 180 minutes from which the risk of AKI starts to increase
[21,22]. It is plausible that the pathophysiologic changes associated
with CPB (systemic inﬂammatory response, changes in renal vasomotor
tone, nonpulsatile blood ﬂow, activation of complement and coagula-
tion pathways, generation of microemboli, and hemolysis) are en-
hanced as the duration of CPB increases, which subsequently increases
Fig. 3. CRATE ROC curves, creatinine, lactate, CPB time, and additive EuroSCORE 1 for predicting CSA-AKI.
136 P. Jorge-Monjas et al. / Journal of Critical Care 31 (2016) 130–138the risk of developing AKI. In a meta-analysis that included 12466 pa-
tients, Kumar et al [22] conﬁrmed that CPB time is an independent
risk factor for CSA-AKI, which, in turn, has a signiﬁcant effect on
overall mortality.
In our center, according to the routine practice in Spain and in
Europe, we perform EuroSCORE 1 in every patient scheduled for cardiac
surgery to assess the preoperative risk. Furthermore, EuroSCORE can be
used to predict not only inhospital mortality, for which it was originally
designed, but also prolonged length of stay and speciﬁc postoperative
complications such as renal failure. These outcomes can be predicted ac-
curately using the standard EuroSCORE, which is very simple and easy
to calculate [23]. deMoura et al [24] found that there is a statistically sig-
niﬁcant association between the values of EuroSCORE 1 and the risk of
developing AKI in the postoperative period after cardiac surgery. Ac-
cordingly, D'Onofrio et al [21] found that patients developing CSA-AKI
have more preoperative comorbidities as summarized by the higher
EuroSCORE value. Two previous studies have combined EuroSCORE
and immunological or biochemical markers with the purpose of
implementing the EuroSCORE's predictive ability, resulting in an im-
provement in the AUC value in both studies [25,26]. Ranucci et al [25]
observed 929 patients in a retrospective study and found that, at the ad-
mission in ICU, the addition of lactate (N4mmol/L) and heart rate (N120
beats per minute) to EuroSCORE value, increases the accuracy of this
score to stratify mortality risk. Similarly, Kennedy et al [27] have
shown that, in conjunction with the logistic EuroSCORE 1, surfaceexpression of ΔCD99 and ΔCD47 and preoperative migratory response
improve the AUC value of EuroSCORE alone in predicting ICU stay.
Thus, previous literature justiﬁes that the use of speciﬁc parameters
along with EuroSCORE can increase the predictive ability oriented to
different targets, in our case in AKI scenario. An update of this mortality
score has recently been published (EuroSCORE II), so that it would
be desirable to carry out a new study that takes into account this
modiﬁcation with the purpose of assessing how this new score ﬁts in
CRATE context.
The advent of novel biomarkers of kidney injury has opened a new
era of early detection and prognosis prediction for CSA-AKI. Two of
the most frequently studied new promising AKI biomarkers to date
are neutrophil gelatinase–associated lipocalin (NGAL or lipocalin
2) and interleukin 18 [17]. However, thesemarkers are notwidely avail-
able in routine practice, and further studies must be developed to ex-
tend its use. Neutrophil gelatinase–associated lipocalin is one of the
most up-regulated genes and proteins early after AKI and one of the
most studiednovel biomarkers in the early detection of AKI [16]. Several
authors [27,28] have studied the role of NGAL in predicting CSA-AKI and
have demonstrated better and earlier predictive power as compared to
creatinine. In addition, Haase-Fielitz et al [29] established that the pre-
dictive power of NGAL is moderately good, with an AUC of 0.82 to
0.83. In our study, CRATE has a predictive power similar to that of
NGAL,with an AUC of 0.89 in the study cohort and 0.81 in the validation
cohort. Although we did not perform a cost-beneﬁt study, it is plausible
Fig. 4. Receiver operating characteristic curve in the validation cohort.
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the cost of the procedure because the variables making up this scale
are of routine use in the treatment and follow-up of cardiac surgery pa-
tients. Consequently, when NGAL or other biomarkers are unavailable,
CRATE could represent a good alternative. Further studies comparing
the predictive power of CRATE and NGAL in the same population
are necessary. One of the advantages of this study is that an external
validation of the scale has been carried out in the same hospital center
at a different time, alongwith a sample of patients from another center,
so the results could be generalizable to other populations.
As in previous studies [30], we did not use the RIFLE urine output
criteria in patient classiﬁcation, which can underestimate in amoderate
way the incidence of CSA-AKI in our population.
In summary, strategies for the prevention of CSA-AKI must consider
identiﬁcation of high-risk patients, being the early postoperative period
the best time to apply a cardiac surgery–speciﬁc score because of the in-
ﬂuence of intraoperative variables in the clinical course of these patients
[9]. CRATE is easy to calculate at the bedside and permits an initial eval-
uation of AKI risk after a short period (1-2 hours) upon admittance to
the ICU, so the clinician could start early interventions to prevent or re-
duce kidney damage. Furthermore, although we have not carried out a
cost analysis, it seems reasonable to think that CRATE is an inexpensive
tool because it uses affordable and widely available variables in clinical
centers where cardiac surgery is a routine practice.Funding
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